IVOM – Intravitreal Injections – Macular Degeneration
Intravitreal injections (IVOM) are a treatment method used in ophthalmology to treat various eye diseases, particularly macular degeneration. Macular degeneration is an age-related disease in which the central vision of the eye deteriorates, leading to a decrease in daily functioning.
IVOM is performed by injecting a small amount of medication directly into the interior of the eye. The site of injection is the vitreous body, which is the gel-like material inside the eye that makes up the majority of the eye’s volume. The injection is usually done under local anesthesia and takes only a few minutes.
The medications used in IVOM are usually anti-VEGF (vascular endothelial growth factor) drugs, which block the action of the VEGF protein that plays a key role in macular degeneration and other eye diseases. VEGF promotes the growth of blood vessels that can contribute to damage to the retina. By blocking VEGF, IVOMs can help slow or even stop the progression of the disease.
IVOM treatment is generally safe and well-tolerated. However, as with any injection, there is a risk of complications such as infections or bleeding in the eye. Therefore, it is important that the injection is performed by an experienced eye doctor.
The frequency and duration of IVOM treatment depends on the severity of macular degeneration. Typically, IVOMs are performed every few weeks or months until symptoms improve or stabilize.
IVOMs are an important treatment option for people with macular degeneration. They can help preserve vision and slow the progression of the disease. However, it is important to note that IVOMs do not provide a cure, but only alleviate symptoms and slow the progression of the disease. Early diagnosis and regular check-ups with an eye doctor can help identify the disease early and choose the best treatment option.